Work

Phase I study of induction chemoimmunotherapy (ICI) with cemiplimab in combination with cisplatin and docetaxel (TPI) in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).

Year: 2025

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e18116

Authors: Omayra Sanchez, Leslie Anne Worona, Emily J Ramos, Vruti Virani, Marshall R. Posner, Scott Roof, Kunal K. Sindhu, Richard Lorne Bakst, Eric Michael Genden, Krzysztof Misiukiewicz

Institutions: Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, Tampa General Hospital, Tisch Cancer Institute, Mount Sinai Hospital

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410805316

FWCI:

Cites:

Cited by:

Related to: 10